U.S. stock night trading volatility: Q32 Bio fell 6.81% in night trading, with active capital flow triggering market volatility attention

U.S. Stock Night Market Movements Q32 Bio fell 6.81% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Stocks with High Trading Volume in the Industry Janux Therapeutics fell 43.57% in the night market. Based on recent key news: On December 1, Janux Therapeutics released a clinical update on its prostate cancer treatment drug JANX007. The document detailed clinical trial results, safety, dosing arrangements, and comparisons with other treatment methods. This update raised market concerns about its drug development progress, leading to a sharp decline in stock price. On December 1, Janux Therapeutics published original content via Business Wire, emphasizing its responsibility for the information. This release failed to alleviate market concerns about its clinical trial results, further exacerbating stock price volatility. The biotechnology industry has been highly volatile recently, and investment should be approached with caution. BeiGene fell 1.14% in the night market. Based on recent key news: On December 1, Amlogic stated in an investor survey that the shipment of edge intelligent chips has significantly increased, becoming one of the company's core growth engines. The notable growth of this business mainly relies on upgrading existing scenarios and expanding new scenarios, enhancing the company's global market coverage and order acquisition capabilities. On December 1, Trina Solar revealed in an investor survey that the global energy storage market is growing strongly, with the company's energy storage shipment target for this year set at 8GWh, planning to double next year. The company has signed overseas orders exceeding 10GWh, expected to be delivered in 2025-2026, driving the expansion of the energy storage business scale and improving profit quality. On December 1, Dongxin Technology pointed out in an investor survey that SLC NAND Flash is forming a substitution effect for NOR Flash in fields such as smart wearable devices, reshaping the memory market landscape and providing new technical pathways for enhancing the performance of smart terminal devices. The energy storage market is growing strongly, and risks should be monitored. Recursion rose 1.38% in the night market. Based on recent key news: On December 1, Recursion Pharmaceuticals announced that it will hold a webinar on December 8 to discuss clinical data on REC-4881 in familial adenomatous polyposis. This news may attract market attention to the company's R&D progress, driving the stock price up. Source: Reuters On December 1, Recursion Pharmaceuticals published relevant information via GlobeNewswire, emphasizing its responsibility for the content. This indicates the company's transparency in information disclosure, which may enhance investor confidence. Source: GlobeNewswire The biotechnology industry has been active recently, with significant capital inflows